Clinical Trials Browser

Phase 2 × INDUSTRY × Inflammation × Clear all

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT02142959 2025-06-03

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Phase 2 Completed

187 enrolled 11 charts

Breast

Breast Neoplasms, Inflammation, Radiodermatitis

NCT05321498 2023-09-28

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Phase 2 Withdrawn

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Tauopathies, Cognitive Dysfunction

NCT00537667 2009-11-26

The SPECTRA Study

Phase 2 Terminated

22 enrolled

Arthritis, Rheumatoid, Inflammation

Clinical Trials

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

The SPECTRA Study